Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Medical Toxicology|January 1, 1986
Prescription-Event Monitoring. Recent experience with 5 NSAIDsN S Rawson, W H InmanBritish Medical Journal (Clinical Research Ed.)|June 18, 1983
Erythromycin estolate and jaundiceW H Inman, N S RawsonJournal of Clinical Epidemiology|January 1, 1990
Prescription-event monitoring: methodology and recent progressN S Rawson, G L Pearce, W H InmanThe British Journal of Psychiatry : the Journal of Mental Science|March 1, 1991
Prescription-event monitoring of 10,895 patients treated with alprazolamJ G Edwards, W H Inman, G L Pearce, et al.BMJ (Clinical Research Ed.)|October 1, 1988
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoringW H Inman, N S Rawson, L V Wilton, et al.BMJ (Clinical Research Ed.)|October 1, 1988
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failureC J Speirs, C T Dollery, W H Inman, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 4, 2000
Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998N S RawsonPharmacoepidemiology and Drug Safety|May 1, 2002
Ethical issues in pharmacoepidemiologic research using Saskatchewan administrative health care utilization dataN S RawsonInternational Journal of Health Services : Planning, Administration, Evaluation|January 1, 1995
The timeliness of new drug approvals in CanadaN S RawsonThe Annals of Pharmacotherapy|July 1, 1995
Impact of preexisting health conditions on the outcome of an adverse drug reaction alerting program: gastrointestinal disorders before piroxicam and sulindac therapyN S RawsonPageof 6